<DOC>
	<DOCNO>NCT00390871</DOCNO>
	<brief_summary>Dexmedetomidine ( Precedex , Hospira ) `` super '' selective alpha2-agonist - 8-10x avid bind alpha2 receptor clonidine - may particularly favorable characteristic continuous i.v . infusion sedative critically ill neuroscience patient . Its combination anxiolysis , analgesia , without undue lethargy may make ideal agent frequent neurological examination important ( 12 ) . Unclear , however , whether Precedex superior current common i.v . sedation protocol , undue concern agent cerebral physiology cortical stimulation .</brief_summary>
	<brief_title>Acute Neurological ICU Sedation Trial ( ANIST )</brief_title>
	<detailed_description>Dexmedetomidine show promise small case series efficacious sedative agent intensive care unit ( ICU ) setting , post-surgical medical patient ( 10,18-21 ) . A recent publication report efficacy small series medical patient ( n=12 ) , part exclusion criteria serious nervous system trauma direct CNS pathology ( 21 ) . A potential advantage dexmedetomidine sedative agent compare current popular class drug , particularly propofol , benzodiazepine , narcotic , nominal effect reduction level arousal . Experience suggest agent may induce effective degree sedation without concomitant loss attentive behavior cognition follow low level auditory tactile stimulation . Thus , neurological assessment may preserve achieve goal non-agitated anxious patient . Additionally , combination sedative/anxiolytic analgesic action dexmedetomidine may permit single drug use sedation pain control post-operative medical ICU period . The cerebral effect alpha2-agonists modestly study clinical environment , normal volunteer ( 13 ) . As expect , cerebral blood flow decrease follow initiation sedative , coincident expect diminishment global cerebral metabolism . No study evaluate dexmedetomidine patient suffer neurological injury , population may benefit agent 's sedative characteristic . Thus , imperative safety &amp; efficacy study carry population medical post-operative neuroscience patient . From intraoperative perspective , dexmedetomidine effectively use sedative awake sedation case ( 1,2,4,16 ) . Some evidence suggest prolonged cognitive deficit may persist beyond sedative action drug ( 4 ) . One concern neuroscience patient population laboratory evidence alpha2-agonists may lower seizure threshold ( 11 ) . Such data show clonidine dexmedetomidine . Therefore , provide comprehensive evaluation lead successful safety &amp; efficacy data sedative , important perform follow three study . All three study do concurrently enrollment three study mutually exclusive . Study 1 : Evaluation Quality Sedation : Does dexmedetomidine provide superior sedative characteristic relative current standard agent patient neurological dysfunction ? The metric study include - 1 . Pharmacodynamic ease sedation : time goal , require nursing intervention goal ; 2 . Quality &amp; consistency sedation : ability examine patient , number require titration intervention ; 3 . Rapid weaning : time residual effect hemodynamic &amp; neurologic ; 4 . Systemic hemodynamic alteration require drug infusion adjustment medical intervention ; 5 . Side effect &amp; toxicity sedative infusion : neurological dysfunction - cognitive , motor , sensory ; electrolyte/hematological/metabolic disturbance , alteration drug level . Study 2 : Alteration Cerebral Physiology : Does Dexmedetomidine alter intracranial physiology either favorable unfavorable manner ? The metric study include - 1 . Measures intracranial pressure ( ICP ) , mean arterial pressure ( MAP ) , cerebral perfusion pressure ( CPP ) ; 2 . Cognitive neurological state ; 3 . Cerebral saturation ( venous ) direct cerebral oximetry ( oxygen tissue level ) subset population specific intracranial device . Study 3 : Alteration Seizure Threshold Potential : Does Dexmedetomidine , use clinical sedation infusion rate , reduce seizure threshold induce pre-ictal EEG change normal seizure-prone patient ? The metric study include - 1 . Continuous scalp epidural EEG monitoring patient seizure disorder ; 2 . Both hemispheres - normal affected seizure monitor compare effect sedative agent `` normal '' vs. epileptic focus .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Study 1 : Neuroscience patient NCCU : 1 . 1880 year age ; 2 . Mechanically ventilated patient ; 3 . Requiring continuous sedation minimum 911 hour ( depend whether pt postoperative ) , yet frequent neurological examination Patients NICSS score &gt; 0 4 . Patient family able provide consent . 5 . Considered guard yet stable neurological state . Not fluctuate intracranial pressure ( ICP ) , cerebral perfusion pressure ( CPP ) , ongoing know cerebral ischemia ICP monitoring place . Study 1 : 1 . Pregnancy . 2 . ICP &gt; 30 mm Hg despite therapy ICP monitor . 3 . CPP &lt; 70 mm Hg monitor . 4 . Occurrence : new cerebral stroke , hemorrhage , change edema CT , increase ICP monitor . 5 . Neuromuscular paralysis . 6 . Nonfunctional cognitive exam follow command . 7 . Renal insufficiency : Serum Creatinine &gt; 2.0 mg/dl estimate Cr Clearance &lt; 40.0 ml/min . 8 . Hepatic disease : AST , ALT &gt; 300 , INR &gt; 1.7 anticoagulant . 9 . Severe COPD baseline arterial pCO2 &gt; 50 . 10 . Suspected alcohol substance withdrawal . 11 . Hypotension require pressor therapy maintain baseline adequate CPP mean arterial pressure . 12 . Cardiac arrhythmia sinus bradycardia ( HR &lt; 60 ) , atrial fibrillation ( &gt; 6 PVC's/min ) 13 . Bradycardia heart rate le 60 beat per minute . 14 . Patient require mechanical ventilation . Study 2 : Critically ill neuroscience patient : 1 . 1880 year age ; 2 . Mechanically ventilate ; 3 . Require Intracranial Pressure ( ICP ) monitoring either subarachnoid bolt ( SA bolt ) , IntraVentricular Catheter ( IVC ) . 4 . Amenable placement intracerebral oxygen sensor jugular bulb catheter . 5 . Have GCS score &gt; 5 require sedation . 6 . Requiring continuous sedation minimum 911 hour ( depend whether pt postoperative ) , yet frequent neurological examination every 12 hour Patients NICSS score &gt; 0 7 . Patient family able provide consent . Study 2 : 1 . Pregnancy ; 2 . ICP &gt; 30 mm Hg despite therapy ; 3 . CPP &lt; 70 mm Hg ; 4 . Occurrence : new cerebral stroke , hemorrhage , change edema CT , increase ICP monitor . 5 . Continuous neuromuscular paralysis 6 . Renal insufficiency : Serum Creatinine &gt; 2.0 mg/dl estimate Cr &lt; 40.0 Clearance ml/min . 7 . Hepatic disease : AST , ALT &gt; 300 , INR &gt; 1.7 anticoagulant . 8 . Severe COPD baseline arterial pCO2 &gt; 50 . 9 . Suspected alcohol substance withdrawal . Study 3 : Critically ill neuroscience patient : 1 . 1880 year age ; 2 . Requiring continuous sedation minimum 911 hr ( depend whether pt postoperative ) , yet frequent neurological examination Patients NICSS score &gt; 0 3 . Patient family able provide consent . 4 . Mechanically ventilated patient ; 5 . Considered guard yet stable neurological state . Not fluctuate ICP , CPP , ongoing know cerebral ischemia . 6 . Presence intraoperatively place GRID electrode array patient require continuous EEG monitoring . Study 3 : 1 . Pregnancy 2 . Occurrence : new cerebral stroke , hemorrhage , change edema CT , increase ICP monitor . 3 . Continuous neuromuscular paralysis 4 . Renal insufficiency : Serum Creatinine &gt; 2.0 Cr Clearance &lt; 40.0 5 . Hepatic insufficiency : AST , ALT &gt; 300 , PT time &gt; 1.7 anticoagulant . 6 . Severe COPD baseline arterial pCO2 &gt; 50 . 7 . Suspected alcohol substance withdrawal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Patient</keyword>
	<keyword>Must</keyword>
	<keyword>Under</keyword>
</DOC>